报价前确认批次文件范围 · 仅供研究使用
  • 规格确认
  • 按需提供批次文件
  • 商务支持 · 西安
  • 确认目的地供应资格
西安诺和达生物科技有限公司

询价清单

发送询价前,请核对产品数量。

查看完整询价清单继续浏览产品此清单仅用于询价,不是结算页面,也不会收取费用。
申请企业账户

Growth Hormone, Secretagogue & IGF Research

This center groups GH-axis hormones, releasing-hormone analogues, secretagogues and IGF-related research materials. Proteins, peptide analogues and small-molecule secretagogues require different identity and potency descriptions.

13 families found for “Growth Hormone & IGF”

Clear filter

Category knowledge center

How to evaluate this research category

This hub separates molecular identity, study design and lot documentation so related families can be explored without turning unlike evidence into a single claim.

13
canonical families
31
目录变体
13
reviewed dossiers
27
链接源记录

What this category includes

  • Growth hormone and releasing-hormone research materials
  • GHRP and ghrelin-receptor secretagogue families
  • IGF and growth-factor related families
  • Human endocrine, animal, mechanistic and analytical records

Identity and interpretation checks

  • With-DAC and without-DAC CJC materials do not share the same pharmacokinetic evidence.
  • A mass specification cannot be converted to IU without product-specific potency information.
  • Endocrine biomarker elevation is not equivalent to a demonstrated clinical benefit.
01

分子类

Distinguish proteins, peptide analogues, fragments and non-peptide secretagogues before comparing evidence.

02

Potency units

Mass, international units and biological activity are not interchangeable without a defined conversion basis.

03

Hormone endpoint

GH pulse, integrated GH, IGF-1, body composition and functional outcomes answer different questions.

Continue the research

Comparisons and editorial analysis

Use fixed, reviewed comparison pages for defined questions and articles for deeper source context. Product dossiers remain the source for catalog identity and variants.

Category questions

Evidence and identity FAQ

These answers define how the category is organized. They do not replace the product specification, lot documents or the cited study record.

Why are GH and IGF families not compared by mass alone?

Their molecular size, biological activity and unit conventions differ; the specification must state the applicable measurement basis.

Does an increase in GH prove a functional outcome?

No. Hormone exposure, downstream biomarkers, body composition and function are distinct endpoints.

What is the main CJC-1295 identity issue?

The classic long-acting human evidence concerns the DAC form; a product called without DAC needs its own explicit sequence and evidence boundary.